X-XSS-Protection: 1; mode=block X-Content-Type-Options: nosniff Strict-Transport-Security: max-age=63072000; includeSubDomains; preload

Research & Technology

The cMet Targeted Agents Platform

The foundation technology of EM Imaging revolves around a common platform platform technology with 3 key components:


  1. Peptide-based binder that allows specific targeting of disease process.
  2. Carrier backbone or pharmacokinetic modulator, coupled to a targeting agent or linker to improve bioavailability/binding affinity and stability.
  3. Fluorescent reporter or radionuclide to allow visualisation and/or therapy.


EM Imaging has a portfolio of agents addressing a number of unmet medical needs. Agents progressed to date have been found to be safe, tolerable, soluble, specific, sensitive and selective.